Wei Wang

11.5k citations
567 papers · 6.5k indexed · 4 hit papers · h-index 38

Wei Wang

505 papers receiving 6.3k citations

Hit Papers

Signaling pathways involved in colorectal cancer: pathoge...16920242026202550100150

Peers

Wei Wang
Comparison fields: 5 of 185
  • Cancer Research 770
  • Physiology 159
  • Molecular Biology 2.4k
  • Immunology 645
  • Biological Psychiatry 62
Replace Wenhua Li with:
Wenhua Li China
Yu Li China
Ssang‐Goo Cho South Korea
Hyeyoung Kim South Korea
Mihalis I. Panayiotidis Greece
Ping Huang China
Peng Cao China
Ning Chen China
Abraham Nyska Israel
Xue Wang China
Wei Wang relative to Wenhua Li China Wenhua Li's profile →
Citations per field
00.5×3.2×
Wenhua Li · 1×
Citations per year

Countries citing papers authored by Wei Wang

Since Specialization
Citations

This map shows the geographic impact of Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wang more than expected).

Fields of papers citing papers by Wei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wang. The network helps show where Wei Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Wang Line = papers co-authored together Wei Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 202411
3 20247
4 20245
5 20245
6 20241
7 20243
8 20241
9 20241
10 20241
11 20244
12 20238
13 20235
14 202311
15 20235
16
Follicular Lymphoma in China: Systematic Evaluation of Follicular Lymphoma Prognostic Models
20223
17 20222
18 202117
19 201991
20
Survival After Abdominal Q-M Type B versus C2 Radical Hysterectomy for Early-Stage Cervical Cancer
20193

About Wei Wang

Wei Wang is a scholar working on Cancer Research, Physiology and Biological Psychiatry, having authored 567 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (39 papers), RNA modifications and cancer (22 papers), Thyroid Disorders and Treatments (20 papers), MicroRNA in disease regulation (19 papers), Cancer therapeutics and mechanisms (18 papers), Herpesvirus Infections and Treatments (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Reproductive biology and impacts on aquatic species (14 papers). The work is most often cited by research in Cancer Research (770 citations), Physiology (159 citations) and Molecular Biology (2.4k citations). Wei Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Hua Tian, Victor Samokhvalov, Liyan Zhang, Wendy Keung, Gary D. Lopaschuk, Shaoguo Ru, Quan Shi, Jianzhong Xiao, Qi Zhou and Gangyi Liu. Their work appears in journals such as Scientific Reports, PLoS ONE, Medicine, Frontiers in Oncology and Ecotoxicology and Environmental Safety.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026